로딩 중…
지수 로딩 중…
Structure Therapeutics Inc.
GPCR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$48.36+0.67%
2026-08-03
Financials
Valuation Metrics
Structure Therapeutics Inc.'s Market Cap is $3.44B. At end of 2025 it was $4.12B. Ranked #1670 of 3,112 in US market (top 54%), #595 of 1,445 on NASDAQ (top 41%), #98 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 36%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.44B | US#1,670/3,112 Sec#98/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-171M | US—/3,112 Sec—/269 |
| Total Assets | $1.51B | US#2,231/3,112 Sec#64/269 |
| Net Assets | $1.45B | US#1,506/3,112 Sec#46/269 |
| Value | ||
| P/B | 2.38x | US#1,412/3,112 Sec#65/269 |
| FCF Yield | -4.63% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -11.79% | US#2,437/3,112 Sec#90/269 |
| ROA | -11.31% | US#2,667/3,112 Sec#105/269 |
| Financial Health | ||
| Debt Ratio | 4.22% | US#37/3,112 Sec#12/269 |
| Total Debt | $6M | US#2,837/3,112 Sec#213/269 |
| FCF | $-159M | US#2,689/3,112 Sec#194/269 |
| Cash | $316M | US#1,384/3,112 Sec#76/269 |
| Current Ratio | 26.16x | US#96/3,112 Sec#16/269 |
| Performance | ||
| 1Y Return | 174.93% | US#113/3,112 Sec#40/269 |
| 1M Return | -9.52% | US#2,569/3,112 Sec#162/269 |
| From 52W High | -49.04% | US#2,763/3,112 Sec#215/269 |
| 1Y MDD | -61.74% | US#2,767/3,112 Sec#219/269 |
| Trading | ||
| Volume | 300,076 shares | US#2,418/3,112 Sec#236/269 |
| Trading Value | $14M | US#2,147/3,112 Sec#166/269 |
| Per Share | ||
| EPS | $-2.39 | US—/3,112 Sec—/269 |
| BPS | $25.62 | US#997/3,112 Sec#23/269 |